![]() |
市場調查報告書
商品編碼
1930089
全球機械呼吸器市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Ventilator Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球機械呼吸器市場在現代醫學中發揮著至關重要的作用,它為因嚴重呼吸系統疾病而無法自主呼吸的患者提供支持。 根據 Fortune Business Insights 預測,機械呼吸器市場規模預計在 2025 年達到 82.1 億美元,並在 2026 年成長至 86.5 億美元。長期來看,預計到 2034 年,該市場規模將達到 137.3 億美元,2026 年至 2034 年的複合年增長率 (CAGR) 為 5.94%。
2025 年,北美在全球呼吸器市場佔主導地位,市場佔有率高達 59.38%,這得益於該地區較高的重症監護室 (ICU) 收治率、先進的醫療基礎設施以及對重症監護技術的積極應用。
市場概覽
機械呼吸器是一種生命維持設備,可為無法自主呼吸的患者提供機械通氣。這些設備廣泛應用於重症監護室 (ICU) 和急診科,其在家庭醫療保健領域的應用也日益增加。 通氣方法大致分為侵入性通氣和非侵入性通氣。由於有創通氣已被臨床證實有效,因此在重症和緊急情況下,有創通氣是首選方案。
慢性呼吸系統疾病盛行率的上升、老年人口的增長以及全球重症監護室(ICU)入院人數的增加,是推動呼吸器需求的主要因素。根據美國重症醫學會(SCCM)統計,美國每年有超過500萬名患者入住ICU,其中約40-50%需要機械通氣,凸顯了這些設備的關鍵作用。
新冠疫情對呼吸器市場的影響
新冠疫情顯著加速了全球對呼吸器的需求。重症患者數量的急劇增加暴露了多個國家醫療基礎設施和呼吸機供應的短缺問題。 根據世界衛生組織(世衛組織)的數據,截至2020年5月18日,全球已報告約470萬例新冠肺炎病例,其中許多患者需要入住加護病房並接受呼吸支援。
在美國,估計有96萬名新冠肺炎患者可能需要呼吸機,而包括功能齊全和非功能齊全的型號在內的呼吸機可用供應量約為20萬台。這種供需缺口迫使各國政府和製造商迅速擴大生產,進一步影響了市場的長期成長。
市場趨勢
擴大產能
主要製造商透過迅速擴大生產來應對疫情。 例如,美敦力公司將產量提高了 40%,飛利浦的目標是將產能提高四倍,而 Getinge AB 的產量則從 2019 年的 1 萬台增加到 2020 年的 26,000 台。這些努力加強了全球供應,並支持了市場的持續擴張。
技術進步
製造商正專注於先進的 ICU 呼吸器、便攜式系統、改進的連接性和增強的監測功能。數位平台和基於雲端的監測系統的整合正在改善患者管理和臨床結果,尤其是在重症監護環境中。
市場驅動因素
加護病房 (ICU) 入院人數增加
由於呼吸系統疾病、吸煙和肥胖等生活方式因素以及傳染病導致的 ICU 入院人數增加是關鍵的成長驅動因素。 德國約有 42% 的 ICU 患者需要使用呼吸機,美國約有 45% 的 ICU 患者需要呼吸支持,這凸顯了已開發市場對呼吸機的強勁需求。
產品創新
領先企業持續推出技術先進的呼吸器。值得關注的產品包括德爾格 (Dräger) 的 Evita V600 和 V800 ICU 呼吸機、漢密爾頓醫療 (Hamilton Medical) 的 HAMILTON-C6 以及日本光電 (Nihon Kohden) 的 NKV-550 系列,這些產品有助於提高臨床效率並促進呼吸器的廣泛應用。
市場限制因子
儘管需求強勁,呼吸器相關併發症(例如呼吸器相關性肺炎 (VAP))仍然是一個挑戰。研究表明,約 80% 的醫院獲得性肺炎病例與呼吸器相關,這可能會限制呼吸器的使用並影響臨床決策。
依類型
此市場細分為成人呼吸器和兒科/新生兒呼吸器。到2026年,成人呼吸器市佔率將達到61.01%,主要驅動因素是老年患者入住加護病房(ICU)人數的增加。
依介面
根據接口,市場分為有創呼吸器和非侵入性呼吸器。由於有創呼吸器在ICU環境中應用廣泛,到2026年,其市佔率將達到88.84%,佔主導地位。
依最終使用者
醫院是最大的最終使用者群體,到2026年將佔56.29%的市場佔有率,主要驅動因素是ICU入院人數的增加和醫院基礎設施的擴建。
預計到2025年,北美呼吸器市場規模將達到48.7億美元,其中美國市場預計到2026年將達到47.4億美元。歐洲佔第二大市場佔有率,預計2026年,德國市場規模將達5.3億美元,英國將達1億美元。
在亞太地區,重症監護室(ICU)入院人數的增加和本地產能的擴大正在推動市場成長。預計到2026年,中國市場規模將達到5.1億美元,日本將達到3.2億美元,印度將達到2.9億美元。
The global ventilators market plays a critical role in modern healthcare by supporting patients who are unable to breathe independently due to severe respiratory conditions. According to Fortune Business Insights, the ventilators market size was valued at USD 8.21 billion in 2025 and is projected to grow to USD 8.65 billion in 2026. Over the long term, the market is forecasted to reach USD 13.73 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 5.94% during the 2026-2034 forecast period.
North America dominated the global ventilators market in 2025 with a 59.38% market share, supported by high ICU admission rates, advanced healthcare infrastructure, and strong adoption of critical care technologies.
Market Overview
Ventilators are life-support devices that provide mechanical ventilation to patients who cannot breathe adequately on their own. These devices are widely used in intensive care units (ICUs), emergency departments, and increasingly in homecare settings. Ventilation can be broadly categorized into invasive and non-invasive modes, with invasive ventilation being preferred in severe and emergency conditions due to its clinically proven effectiveness.
The rising prevalence of chronic respiratory diseases, growing geriatric population, and increasing number of ICU admissions worldwide are major factors driving demand for ventilators. According to the Society of Critical Care Medicine, more than 5 million patients are admitted to ICUs annually in the U.S., with approximately 40-50% requiring mechanical ventilation, highlighting the essential role of these devices.
Impact of COVID-19 on the Ventilators Market
The COVID-19 pandemic significantly accelerated demand for ventilators globally. The sudden surge in critically ill patients exposed gaps in healthcare infrastructure and ventilator availability across multiple countries. According to the World Health Organization, around 4.7 million COVID-19 cases were reported globally as of May 18, 2020, many of which required ICU admission and respiratory support.
In the U.S., estimates suggested that nearly 960,000 COVID-19 patients could require mechanical ventilation, compared to an available supply of approximately 200,000 ventilators, including full-featured and non-full-featured devices. This supply-demand gap prompted governments and manufacturers to rapidly scale production, further influencing long-term market growth.
Market Trends
Scaling Up Production Capacity
Key manufacturers responded to the pandemic by rapidly increasing production. For instance, Medtronic increased production by 40%, Philips targeted a fourfold capacity increase, and Getinge AB expanded output from 10,000 units in 2019 to 26,000 units in 2020. These initiatives strengthened global supply and supported sustained market expansion.
Technological Advancements
Manufacturers are focusing on advanced ICU ventilators, portable systems, improved connectivity, and enhanced monitoring features. The integration of digital platforms and cloud-based monitoring systems is improving patient management and clinical outcomes, particularly in critical care environments.
Market Drivers
Rising ICU Admissions
The increasing number of ICU admissions due to respiratory diseases, lifestyle factors such as smoking and obesity, and infectious diseases is a major growth driver. In Germany, approximately 42% of ICU patients require mechanical ventilation, while in the U.S., around 45% of ICU admissions need ventilatory support, underscoring strong demand across developed markets.
Product Innovation
Key players continue to launch technologically advanced ventilators. Notable introductions include Drager's Evita V600 and V800 ICU ventilators, Hamilton Medical's HAMILTON-C6, and Nihon Kohden's NKV-550 series, supporting clinical efficiency and expanding adoption.
Market Restraints
Despite strong demand, the market faces challenges from ventilator-associated complications such as ventilator-associated pneumonia (VAP). Studies indicate that around 80% of nosocomial pneumonias are linked to mechanical ventilation, which may limit usage in certain cases and impact clinical decision-making.
By Type
The market is segmented into adult and pediatric & neonatal ventilators. The adult segment dominated with a 61.01% market share in 2026, driven by higher ICU admissions among the elderly population.
By Interface
Based on interface, the market includes invasive and non-invasive ventilators. The invasive segment held a dominant 88.84% share in 2026, due to higher adoption in ICU settings.
By End User
Hospitals represent the largest end-user segment, accounting for 56.29% market share in 2026, supported by rising ICU admissions and expanding hospital infrastructure.
The North America ventilators market was valued at USD 4.87 billion in 2025, with the U.S. market projected to reach USD 4.74 billion by 2026. Europe holds the second-largest share, with Germany projected at USD 0.53 billion and the U.K. at USD 0.10 billion by 2026.
In Asia Pacific, growth is driven by increasing ICU admissions and local manufacturing. By 2026, China is projected to reach USD 0.51 billion, Japan USD 0.32 billion, and India USD 0.29 billion.
Conclusion
The global ventilators market, valued at USD 8.21 billion in 2025, is projected to grow to USD 8.65 billion in 2026 and reach USD 13.73 billion by 2034. Continuous growth in ICU admissions, technological advancements, and rising demand for critical care equipment are expected to support market expansion during the forecast period.
Segmentation By Type
By Interface
By End-User
By Geography